iShares Nasdaq Biotechnology ETF

Find Ratings Reports
IBB : NASDAQ : Financial
$295.08 -2.40 | -0.81%
Today's Range: 292.85 - 298.45
Avg. Daily Volume: 1,215,400
09/28/16 - 4:00 PM ET
RETURN AND EXPENSE COMPARISON (as of Jan 2016)
IBB Return and Expenses Comparison Chart
1 Month: -5.61% 1 Year: -16.64%
3 Month: -0.34% 3 Year: 11.79%
6 Month: 6.78% 5 Year; 24.69%
Year-to-Date -16.95%    
Last Dividend
(06/21/2016)
$0.16    
Last Cap Gain 0.0    
Expense Ratio 0.47%    
MOST RECENT RATINGS CHANGES
Date Price Action From To
08/31/2016 $280.89 Downgrade HOLD SELL
02/29/2016 $254.09 Downgrade BUY HOLD
09/30/2014 $273.63 Upgrade HOLD BUY
08/31/2014 $276.55 Downgrade BUY HOLD
Sector Allocation
IBB Sector Allocation Chart
Basic Materials0.0%
Capital Goods0.0%
Technology0.0%
Consumer Staples0.0%
Healthcare92.83%
Energy0.0%
Finance0.0%
Transportation0.0%
Communication Services0.0%
Utilities0.0%
Miscellaneous0.04%
RETURN AND VOLATILITY MEASURES
 1 Year3 Year
Alpha-34.74%-3.11%
Beta1.97%1.35%
R-squared57.0%32.0%
Standard Deviation33.18%26.24%
Semi-deviation7.01%5.13%
Definitions:
Alpha - measures the portfolio manager's contribution to performance that is independent of the benchmark.
Beta - measures the portfolio sensitivity to movements in the market relative to the selected underlying benchmark.
R-squared - mesausres how closely the derived forecast was able to explain the performance of the last three years. It also measures diversification with lower number indicating more independence from benchmark.
Standard deviation - measures how closely actual values matched the forecasted values for performance.
Semi-deviation - only considers values that fall below the risk free rate of return.
Top Ten Holdings
Amgen Inc 8.42%
Gilead Sciences Inc 8.41%
Biogen Inc 8.02%
Celgene Corp 7.93%
Regeneron Pharmaceuticals Inc 7.21%
Illumina Inc 4.31%
Alexion Pharmaceuticals Inc 3.95%
Vertex Pharmaceuticals Inc 3.71%
Incyte Corp 2.82%
Biomarin Pharmaceutical Inc 2.77%
 

Latest Stock Upgrades/Downgrades